July 2015 FDA Recall Daytrana by Noven Pharmaceuticals, Inc.
D-0008-2016 - Defective Delivery System

This Class II drug recall was voluntarily initiated by Noven Pharmaceuticals, Inc. on July 27, 2015 for the product Daytrana. The FDA reported the reason for recall as defective delivery system. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0008-2016

Reason for Recall
Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.
Initiated
07-27-2015
Reported
10-14-2015
Quantity
125,250 Patches

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Noven Pharmaceuticals, Inc.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Daytrana (methylphenidate transdermal system), 30 mg over 9 Hour Patches (3.3 mg/hr), 30 Ct Carton, Rx Only, Manufactured for: Noven Therapies, LLC., Miami, FL 33186, by: Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC: 68968-5555-3

Batch or Lot Expiration Information

Lot# : 75983, Expiry: 11/15